Carbzah Solution
NDC Package 71085-080-07
Package Information
Carbzah (carbinoxamine maleate) solution is carbinoxamine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. This formulation utilizes a solution delivery system. Marketed by Ipg Pharmaceuticals, Inc., this product is identified by NDC 71085-080 and is authorized under FDA application ANDA040458.
Identification & Billing
- RxCUI: 1010696 - carbinoxamine maleate 4 MG in 5 mL Oral Solution
- RxCUI: 1010696 - carbinoxamine maleate 0.8 MG/ML Oral Solution
- RxCUI: 1010696 - carbinoxamine maleate 0.8 MG/ML Oral Syrup
- RxCUI: 1010696 - carbinoxamine maleate 4 MG per 5 ML Oral Solution
- RxCUI: 2730039 - CARBZAH 4 MG in 5 mL Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71085 - Ipg Pharmaceuticals, Inc.
- 71085-080 - Carbzah
- 71085-080-07 - 473 mL in 1 BOTTLE, PLASTIC
- 71085-080 - Carbzah
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71085-080-07 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Carbzah, a human prescription drug labeled by Ipg Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This solution is formulated for oral use and contains carbinoxamine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ipg Pharmaceuticals, Inc. on June 01, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Carbinoxamine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms include rash, watery eyes, itchy eyes/nose/throat/skin, cough, runny nose, and sneezing. This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. By blocking another natural substance made by your body (acetylcholine), it helps dry up some body fluids to relieve symptoms such as watery eyes and runny nose. Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How is this Ipg Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71085008007. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.